Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Acelyrin (SLRN) Insider Trading & Ownership

Acelyrin logo

Acelyrin (NASDAQ:SLRN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
13.60%
Number Of
Insiders Buying
(Last 3 Years)
4
Amount Of
Insider Buying
(Last 3 Years)
$23.70M
Number Of
Insiders Selling
(Last 3 Years)
4
Amount Of
Insider Selling
(Last 3 Years)
$258.56K
Get SLRN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Acelyrin stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SLRN Insider Buying and Selling by Quarter

Acelyrin Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/17/2025
Amar Murugan
Insider
Sell3,913$2.74$10,721.62  
3/17/2025
Mina Kim
CEO
Sell17,986$2.74$49,281.64  
7/17/2024
Daniel J Becker
Director
Sell1$6.86$6.86  
2/20/2024
Shao-Lee Lin
CEO
Sell15,701$7.60$119,327.60  
1/2/2024
Shao-Lee Lin
CEO
Sell10,691$7.41$79,220.31  
5/9/2023
Beth C Seidenberg
Director
Buy60,000$18.00$1,080,000.00  
5/9/2023
Biopartners Fund Ii Westlake
Major Shareholder
Buy1,250,000$18.00$22,500,000.00  
5/9/2023
Mardi Dier
CFO
Buy5,556$18.00$100,008.00  
5/9/2023
Ronald Oyston
Insider
Buy1,000$18.00$18,000.00  
(Data available from 1/1/2013 forward)

SLRN Insider Trading Activity - Frequently Asked Questions

The list of insiders at Acelyrin includes Amar Murugan, Beth C Seidenberg, Biopartners Fund Ii Westlake, Daniel J Becker, Mardi Dier, Mina Kim, Ronald Oyston, and Shao-Lee Lin. Learn more on insiders at SLRN.

13.60% of Acelyrin stock is owned by insiders. Learn more on SLRN's insider holdings.

The following insiders have sold SLRN shares in the last 24 months: Amar Murugan ($10,721.62), Daniel J Becker ($6.86), and Mina Kim ($49,281.64).

Insiders have sold a total of 21,900 Acelyrin shares in the last 24 months for a total of $60,010.12 sold.



This page (NASDAQ:SLRN) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners